FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Biologics

CBER AI/ML Web Page

CBER launches a new Web page on its approach to using AI/ML in regulatory oversight of products it regulates.

latest-news-card-1
Medical Devices

Fujifilm AI Colonoscopy Polyp Detector Cleared

FDA clears a Fujifilm Healthcare Americas 510(k) for CAD EYE, an artificial intelligence detection system for endoscopic imaging.

latest-news-card-1
Human Drugs

FDA OKs Tryvio as Add-on for Hypertension

FDA approves an Idorsia NDA for Tryvio (aprocitentan) for treating hypertension in combination with other antihypertensive drugs in adult patients who...

latest-news-card-1
Federal Register

Criteria on Difficult Compounding Lists

Federal Register notice: FDA proposes to establish criteria for the lists of drug products or drug categories that present demonstrable difficulties f...

latest-news-card-1
Human Drugs

J&Js Edurant PED Approved for Pediatric HIV-1

FDA approves Johnson & Johnsons Edurant PED (rilpivirine) for treating HIV-1 in combination with other antiretroviral therapies in treatment-nave chil...

latest-news-card-1
Medical Devices

Panel to Discuss Non-invasive Ocular Pump

FDA asks the Ophthalmic Devices Panel to discuss safety and other issues related to the Balance Ophthalmics FSYX ocular pump to lower intraocular pres...

latest-news-card-1
Human Drugs

Key Patient Long Covid Meeting Themes

FDA reports the key themes that emerged from a 3/2023 virtual meeting with patients and caregivers on long Covid.

latest-news-card-1
Human Drugs

FDA Warning Letters on Chinese Syringes

FDA sends Warning Letters to Jiangsu Shenli Medical Production Co. Ltd, a China-based plastic syringe manufacturer, and Medline Industries and Sol-Mil...

latest-news-card-1
Human Drugs

FDA OKs Chronic Rhinosinusitis Nasal Spray

FDA approves an Optinose NDA for Xhance (fluticasone propionate) nasal spray for treating chronic rhinosinusitis without nasal polyps in patients 18 y...